The extended review for Elinzanetant is supported by data from the Phase III OASIS 1, 2, and 3 trials, which supported the ...

After losing 3,500 employees in April—19% of its workforce due to congressional budget cuts—the FDA is now struggling to meet ...

The U.S. Food and Drug Administration has extended its review of Bayer's experimental menopause relief drug, the German ...

The agency told Bayer it needs additional time to review the non-hormonal drug, called elinzanetant. Regulators in Canada and ...

Gusttavo netted a fifth 10 minutes after the restart, at which point Ten Hag made another wave of changes. On came Edmond ...

Bayer is a deep contrarian play, trading at less than 6x P/E, with potential for 100%+ upside if litigation risks subside.

Bayer says this is just the beginning, with 240,000 additional credits in the pipeline and expected to be issued as carbon credits later this year. A regenerative tonne is equal to approximately ...

An independent playing philosophy, full-time coaches and the long-term objective of the first-team squad: With a new ...